ReviewSeminars in respiratory and critical care medicine2010
Rheumatologic manifestations of sarcoidosis.
Review in Seminars in respiratory and critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 100 citations in OpenAlex.
- Unveiling the unexpected: Skeletal sarcoidosis with an extraosseous soft-tissue mass in the ligamentous portion of sacroiliac joint.Radiology case reports · 2026Article
- Ultrasound-guided core needle joint biopsies in children: pathological findings, diagnostic performance, and clinical relevance.Pediatric radiology · 2026Article
- A 27-year-old woman presenting with fever and neck mass sensation.Journal of Yeungnam medical science · 2026Article
- Challenging diagnosis: unveiling extensive multisystemic sarcoidosis with musculoskeletal involvement through a clinically ambiguous soft tissue mass in the palm.Skeletal radiology · 2025Article
- Immunological Disorders: Gradations and the Current Approach in Laboratory Diagnostics.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025Review
- [Sequential autoimmunity? The rare case of MDA5 dermatomyositis and sarcoidosis].Zeitschrift fur Rheumatologie · 2025Article
- Rheumatic Manifestations of Sarcoidosis.Diagnostics (Basel, Switzerland) · 2024Review
- [Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].Wiener klinische Wochenschrift · 2024Article
- Beyond the Usual Suspects: Primary Premaxilla Sarcoidosis.Iranian journal of otorhinolaryngology · 2024Article
- A single-center rheumatology experience of sarcoidosis: observations from 70 patients.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023Article
- [Sarcoidosis].Zeitschrift fur Rheumatologie · 2023Article
- Evaluation of Clinical, Laboratory, and Radiologic Findings of Pulmonary and Extrapulmonary Involvement in Sarcoidosis.Tanaffos · 2023Article
- Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.Rheumatology international · 2022Article
- Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.Clinical rheumatology · 2022Review
- Musculoskeletal Manifestations of Sarcoidosis.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2022Review
- Review
- Review
- Ankle arthritis - an important signpost in rheumatologic practice.Rheumatology (Oxford, England) · 2021Review
- Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study.Frontiers in medicine · 2020Article
- Refractory Sarcoidosis: A Review.Therapeutics and clinical risk management · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 7 institutions in 2 countries.
Funding
Abstract
Sarcoidosis is a systemic, clinically heterogeneous disease characterized by the development of granulomas. Any organ system can be involved, and patients may present with any number of rheumatologic symptoms. There are no U.S. Food and Drug Administration-approved therapies for the treatment of sarcoidosis. Diagnosing sarcoidosis becomes challenging, particularly when its complications cause patients' symptoms to mimic other conditions, including polymyositis, Sjögren syndrome, or vasculitis. This review presents an overview of the etiology of and biomarkers associated with sarcoidosis. We then provide a detailed description of the rheumatologic manifestations of sarcoidosis and present a treatment algorithm based on current clinical evidence for patients with sarcoid arthritis. The discussion will focus on characteristic findings in patients with sarcoid arthritis, osseous involvement in sarcoidosis, and sarcoid myopathy. Arthritic conditions that sometimes coexist with sarcoidosis are described as well. We present two cases of sarcoidosis with rheumatologic manifestations. Our intent is to encourage a multidisciplinary, translational approach to meet the challenges and difficulties in understanding and treating sarcoidosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.